PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Detail   |   Print    Next page > 
     
ICP DAS-BMP Brings Advanced Medical TPU Portfolio to Medical Manufacturing Asia 2026
2026-08-25T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Antengene Receives Clinical Trial Approval in Australia for Phase I ATTRACT Study of ATG-201 (CD19 x CD3 TCE) in B Cell-related Autoimmune Diseases
2026-08-25T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
WuXi XDC Delivers Strong First Half 2026 Performance, with Improving Margins and Profitability Further Strengthening Global ADC/XDC CRDMO Leadership
2026-08-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform"
2026-08-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
INDONESIAN HEALTHCARE TRAVEL TO MALAYSIA HITS RECORD RM2.2 BILLION AS MHX RETURNS TO YOGYAKARTA
2026-08-24T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy
2026-08-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Pulnovo Medical Announces First Two U.S. Patients Enrolled in PULSE-LHD IDE Clinical Trial of Pulmonary Artery Denervation in Treating Pulmonary Hypertension Associated with Left Heart Disease
2026-08-24T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
2026-08-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Antengene Announces 2026 Interim Results: Achieves First‑Ever Profitability and Accelerates Value Creation Through Innovative R&D
2026-08-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
2026-08-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.